March 1, 2018 6:00 pm - 8:00 pm

Masraff’s

1753 Post Oak Blvd., Houston, TX 77056

    The Missing Link in Addiction Evaluation and Treatment

    Join ASAM McGovern Award Winner, Dr. Mark Gold for our Professional Lecture

    Abstract … Drugs and Depression:

    Many prominent experts in addiction psychiatry have advanced the theory of self-medication to explain why a person might become cocaine vs an opioid-dependent user vs an alcoholic. It is true that smoking mothers often have smoking children but gene expression, rather than self-medication may help explain this finding. But, self-medication may explain why depressed or patients with Schizophrenia are often smokers. What the person brings to the drug challenge is complicated and often times ignored. AA and 12 Step programs work especially well in providing an alternative peer group and a positive when stopping drugs, even when use is associated with dire consequences are so negative. While MATs have been emphasized, premorbid Psychiatric history and comprehensive evaluations have been ignored. It is not surprising that the opioid overdose epidemic was not studied but ipso facto attributed to accidental overdoses, rather than a combination of suicide, accident, and poisonings. Dr. Mark Gold’s 40+ years of addiction research has not focused on self-medication theory, but on the drug-brain-receptor reactions. Drugs target the brain’s pleasure or rewarding centers, the nucleus accumbens, and have similar neurotoxic effects. Drugs can change the brain and induce changes that make using feel imperative. In post addiction and recovery programs, depression, sleep, appetite, sexual, anxiety, concentration, memory and other very real problems emerge. Diagnosis and treatment of co-morbid diseases are essential, and often times can promote long-term sobriety and recovery. Transcranial Magnetic Stimulation and other novel approaches are being tried to help the recovery of structure and function of the brain’s reinforcement systems.

    Objectives:

    The learner will describe the wait and see hypothesis utilized in many centers, the self-medication hypothesis described by addiction psychiatrists, and the Gold hypothesis of drug-induced neurotoxicity causing anhedonia and depression.

    The learner will review the most common comorbidities and also how diagnosis and treatment can improve outcomes for both addiction and psychiatric comorbid disease.

    Event Details

    We’ve met capacity for this event. Registration is closed.

    If you would like to be placed on a cancellation list, please contact Leslie Downing at [email protected] She will contact you if a seat becomes available.

    Date: Thursday, March 1

    Time: Dinner at 6 PM
    Presentation begins at 6:30 PM

    Presenter: Mark S. Gold, M.D., DLFAPA, DFASAM

    Location: Masraff’s, 1753 Post Oak Blvd. Houston, TX 77056

    1 CME/CE offered*

    Questions? Contact Leslie Downing at
    (713) 870-0274 or
    [email protected]

    About Mark S. Gold, M.D., DLFAPA, DFASAM

    Mark S. Gold is a translational researcher, author, and inventor best known for his work on the brain systems underlying the effects of opiate drugs, cocaine, and food. Currently, an Adjunct Professor and Professor-in-Residence, he is often lecturing, mentoring, and teaching in the Department of Psychiatry at Washington University in St Louis. He is also an active member of the National Council for the Institute for Public Health at Washington University School of Medicine. He is an author and inventor who has published over 1000 peer reviewed scientific articles, texts, and practice guidelines.

    Dr. Gold is a multiple patent holder and translational researcher who has been a mentor of many of the leaders in translational medicine, addiction medicine, neuroscience, Addiction and Obesity Medicine. For example, Gold is the senior author on the discovery paper and with his Yale University School of Medicine colleagues, was awarded a patent for the discovery of new uses for clonidine which remains widely used for opiate withdrawal and pain management. Gold and colleagues were recently awarded a patent for a novel treatment for obesity (2017). He has received the annual ASAM McGovern Award, DARE, DEA, PATH and White House Award for Lifetime Achievement. Former Obama Drug Czar Boticelli referred to him as the father of Medically Assisted Treatment because of his 4 + decades of work proving that drug addiction is a brain disease, what happens in the brain, and what can be done to help.

    Dr. Gold has been recognized for this work by the University of Florida’s Technology Transfer program as a pioneering inventor. Gold has been awarded Distinguished Alumni Awards from Washington University in St Louis, the University of Florida, and Yale University. He was Professor, Eminent Scholar, Distinguished Professor, Distinguished Alumni Professor, Emeritus Eminent Scholar during his 25 years at the University of Florida. He remains active in physician and executive health, evaluation and recovery serving on the State of Florida’s Board and also doing research showing how and why addiction treatment for physicians and executives work so well…and why everyone deserves such treatment.

    Dr. Mark Gold
    Dr. Mark Gold, M.D., DLFAPA, DFASAM

    *Physicians: The activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    CME Outfitters, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This continuing education offering has been submitted for approval for 1 CEU with NAADAC, NASW and TMHT through our partners in education, TopCat Schools.